TOP2A and Decreased total leukocyte count: Both typical (e.g., Doxorubicin, Etoposide) or atypical (e.g., Vosaroxin) Top2α poisons share very similar clinical safety profiles, with the most commonly observed adverse events (AE) being leukopenia and nausea/vomiting [62,63,64].